Zacks Investment Research
28 Oct 2025, 23:31 UTC · 49w ago
Impact · against what's priced in
Community Healthcare Trust (CHCT) shows strong fundamental momentum with a significant EPS jump to $0.56 and a modest revenue beat. The results indicate a positive trend in profitability and top-line growth that exceeds consensus expectations.
No priced-in read yet
What the story claims
3 claims · scored −1 bearish … +1 bullish
Community Healthcare Trust (CHCT) reported Q3 2025 EPS of $0.56, significantly increasing from $0.04 in the prior year quarter.
So whatA massive year-over-year increase in earnings per share typically signals strong fundamental improvement and positive sentiment for the stock.
More positive than 78% of claims this week
Community Healthcare Trust's Q3 2025 revenue grew 4.9% year-over-year to $31.09 million.
Continue reading
5 related stories
The company reported a substantial year-over-year EPS increase from $0.04 to $0.56 and a 4.9% revenue growth to $31.09 million, beating Zacks consensus estimates for both metrics.
Read from the article alone
Scored by the NIS engine · methodology.
More positive than 53% of claims this week
CHCT's reported EPS and revenue both beat Zacks Consensus Estimates by 3.7% and 0.96% respectively.
So whatBeating analyst expectations provides a positive short-term catalyst, though the revenue beat is marginal.
More positive than 44% of claims this week
Which stocks this story touches
More positive than 74% of ticker scores this week
The company reported revenue and EPS growth that beat Zacks Consensus Estimates.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
Proactive Investors
49m ago
−6.2%
Price is moving against the score
$13.58 vs $14.47 close before publication (Oct 28) · not market-adjusted
CHCT chart →
